CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung 会议论文
作者:  Goss, G.;  Cobo, M.;  Lu, S.;  Syrigos, K.;  Lee, K. H.
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders 会议论文
作者:  Li, W.;  Gadgeel, S. M.;  Soria, J. C.;  Felip, E.;  Cobo, M.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Phase III trial of afatinib vs erlotinib in patients (pts) with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8): EGFR molecular aberrations and survival outcomes 会议论文
作者:  Park, K.;  Li, W.;  Zhou, C.;  Felip, E.;  Cobo, M.
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace